In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

Widespread chronic pain in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome significantly affected daily activities.

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Neoadjuvant semaglutide before metabolic and bariatric surgery is not beneficial in terms of weight loss, according to study findings.

HealthDay News — People who take over-the-counter (OTC) pain relievers after a concussion may recover faster than those who do not, according to a study scheduled for presentation at the annual ...

Only 17% of adults say they want to see Medicaid funding decreased, while 42% think funding should increase and 40% think it should be kept about the same.

A group of former US CDC employees is fighting to get their jobs back after being abruptly laid off last month.

Stopping GLP-1 RA treatment 14 days before total joint arthroplasty can minimize risks for complications, according to study findings.

Clinical symptoms of depression and anxiety were present in 39.3% and 40.2% of patients with chronic pain, respectively. HealthDay News — Approximately 40 percent of adults with chronic pain ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.